Precigen's Strong Second Quarter Signals Significant Growth, Validates AdenoVerse Platform; PRGN-2009 Advances in HPV-Driven Cancers 25 August
Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth 04 August
Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4 21 July
